Chesterford Research Park has welcomed Broken String Biosciences as the latest occupier of the newly completed Sidney Sussex Building, which provides more than 56,000 sq ft of research and development facilities for life science companies. Broken String will take Suite 8, bringing together its growing team within a single, purpose-built laboratory and office environment.
The relocation reflects Broken String’s continued growth and long-term commitment to Chesterford Research Park. In moving across to the Sidney Sussex Building, the company gains a modern, fully fitted laboratory environment designed to provide the flexibility and infrastructure required as the business continues to evolve.
The three-storey Sidney Sussex Building provides a total of 10 self-contained, R&D suites (from 2,245 sq ft), designed to enable growing science businesses to move in quickly whilst minimising upfront capital investment. Each suite combines high-specification fitted laboratory space with integrated write-up / office accommodation, with the flexibility for occupiers to expand as their requirements evolve.
Broken String Biosciences develops technologies that enable researchers to directly measure DNA breaks across the genome, providing new insight into genome instability across disease research and therapeutic development. Its proprietary INDUCE-seq® platform enables sensitive, genome-wide mapping of DNA double-strand breaks, supporting applications ranging from genome editing safety to understanding the underlying biology of disease.
Terry Pizzie, CEO, Broken String, said: “We’re entering an exciting next phase for Broken String, with new applications for our technology and growing commercial momentum. The Sidney Sussex Building gives us the high-quality laboratory and office space we need as the business develops, while allowing us to remain at Chesterford Research Park, which has been a great home for the company. We’re very pleased to be continuing that journey here.”
Julian Cobourne, Head of Regional Investment Management, Aviva Investors, added: “The Sidney Sussex building was designed specifically to support life science companies through their growth journey, so it is particularly rewarding to see existing residents like Broken String choosing to continue its growth within Chesterford Research Park. It speaks to the Park’s reputation as a leading UK life science location with high-quality, flexible laboratory space that allows them to scale, and our long-term vision of supporting existing occupiers whilst welcoming new ventures to the community. It is a great example of how Aviva Investors is helping the UK get ready for the future by supporting companies at the cutting-edge technological innovation.”
Will Brown, Director – Commercial, Cheffins, commented: “It’s always satisfying to help an existing occupier find the right space as its requirements evolve. The Sidney Sussex Building offers the quality and flexibility that growing life science companies need, and we’re pleased to have worked with Broken String to secure accommodation that supports both its current operations and future growth plans.”
Chesterford Research Park combines high-quality laboratory accommodation with an established life science community, all within a 250-acre parkland setting. Its central amenities, sustainable transport options and excellent connections to Cambridge, London and Stansted Airport continue to make it an attractive destination for science and technology businesses looking to recruit, retain and grow talented teams.
The Sidney Sussex Building forms part of Chesterford Research Park’s long-term strategy to deliver flexible, high-quality laboratory accommodation for companies at every stage of their growth. In addition to supporting existing occupiers as they expand, the building also provides opportunities for new businesses to join one of the UK’s leading life science communities.
Chesterford Research Park’s owners are advised by the Park’s joint commercial agents, Cheffins and Savills, together with development partners Churchmanor Estates Company plc
